Pushkal Garg, CMO & EVP Development & Med Affairs at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 52,592 shares at $285.00 ($15.0M) on 2025-01-27, disclosed to the SEC on 2025-01-29.
Scheduled sale ($15.0M) by CMO & EVP Development & Med Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| ALNY | SELL | 2026-03-02 | $1.5M | — | Filing → |
| ALNY | SELL | 2026-02-17 | $695K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |